Skip to content

Organon OGN Debt Maturity - 2027

Debt Maturity - 2027 at other companies

PBH
Prestige Consumer HealthcarePBH
$40M-90.0%
Merck & Co. logo
Merck & Co.MRK
$2.1B+40.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$580.09M
Abbott logo
AbbottABT
$650M+11.5%
Bausch + Lomb logo
Bausch + LombBLCO
$28M-98.5%
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's debt maturity - 2027.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's debt maturity - 2027?
Organon (OGN) reported debt maturity - 2027 of $9M in Q1 2026.
How has Organon's debt maturity - 2027 changed year-over-year?
Organon's debt maturity - 2027 decreased by 99.7% year-over-year, from $3.49B to $9M.
What does debt maturity - 2027 mean?
The specific principal amount of debt obligations scheduled to mature in the year 2027. This metric is essential for assessing the company's liquidity risk and refinancing requirements in a specific future period. It helps investors understand the timing of potential cash outflows related to debt repayment.